Home » Newsletters » BioWorld Science

BioWorld Science

July 30, 2013

View Archived Issues

Data from clinical evaluations of a recombinant fusion protein for patients with hemophilia B

Novartis patents describe prostanoid IP receptor agonists

Kyowa Hakko Kirin offers overview of first half 2013

Researchers at Acesion Pharma design novel potassium channel blockers

FDA approves Injectafer for treatment of iron deficiency anemia

Takeda Pharmaceuticals divulges novel MCH1 receptor antagonists

Oral LC-23-1306 shows potential as once-daily antiplatelet therapy in healthy volunteers

NICE issues final guidance recommending GSK's Revolade for blood disorder

A novel CNTF-derived peptide restores cognitive impairment in vivo

Eisai receives positive CHMP opinion for Zonegran in pediatric patients

uniQure begins phase I trial of gene therapy for Parkinson's disease

Neuren reports data for NNZ-2591 from fragile X model

New SYK inhibitors synthesized at Roche

California Stem Cell submits phase III protocol to FDA for treatment of metastatic melanoma

Bristol-Myers Squibb discloses novel IRAK-4 inhibitors

Novel sleep deprivation-induced animal model for Alzheimer's disease described

CereSpir signs letter of intent to acquire rights to Chiesi's CHF-5074

Stelara receives positive CHMP recommendation

Synta Pharmaceuticals reports data from ENCHANT-1 trial

Bionomics commences IND-enabling studies for BNC-101

Pfizer Japan and Takeda Pharmaceutical launch Xeljanz for RA in Japan

Array BioPharma and Celgene to collaborate on program targeting novel inflammation pathway

IDRI and Zydus form collaboration for visceral leishmaniasis vaccine candidate

Rebiotix obtains IND approval for phase II trial of microbiota restoration therapy

Simponi gets positive opinion in Europe for ulcerative colitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....